| Value | ₹0.02 Cr |
|---|
BSE filing, NSE: LYKALABS. Summary written from the filing by ALFA Finder's alert engine.
Lyka Labs Ltd: key numbers
- Share price
- ₹76.60
- Market cap
- ₹273.4 Cr
- Revenue (annual)
- ₹128.4 Cr
- Net profit (annual)
- ₹-10.03 Cr
- P/E (TTM)
- -64.2×Sector 45.9×
- Promoter holding
- 58.45%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lyka Labs Ltd
All →Lyka Labs Other Announcement
Lyka Labs filed its quarterly shareholding pattern for the period ended September 30, 2026 under Regulation 31. Promoter and public holdings are reported as of that date, with no transaction or corporate event.
Lyka Labs Management Change
Lyka Labs re-appointed Neeraj Golas as Non-Executive Independent Director for 36 months, effective 16 January 2027. The board approved it at its 30 October 2026 meeting.
- Execution
- 36 months from 16 January 2027
Lyka Labs Results Update
Q2 FY27 standalone revenue rose 34.06% to Rs. 4,419.95 Lacs. Standalone net profit swung to Rs. 131.50 Lacs from a loss.
Lyka Labs Q2 FY27 Results: Turns Profitable, Net Profit ₹1.3 Cr
Lyka Labs approved unaudited standalone results for the half year ended 30 September 2026. The board also sought postal ballot approval for an independent director's reappointment.
- Key figure
- Net profit ₹1.3 Cr
Lyka Labs Board Meeting Date
Lyka Labs has intimated that its Board will meet on 30 October 2026 to consider Q2 FY27 unaudited financial results. No decisions or figures are reported in this prior intimation.
Lyka Labs Results Correction
Lyka Labs Limited submitted a revised press release for Q1 FY27 results to correct typographical errors. The company reported a consolidated net profit of Rs. 2.05 Crore.
Other legal & regulatory announcements
All →Vodafone Idea Legal & Regulatory
Vodafone Idea disclosed a TRAI financial disincentive of Rs. 0.89 Crore for quarter-Dec 2024 non-compliance. The company is reviewing the order and assessing its response.
- Value
- ₹0.89 Cr
Aspinwall and Company Legal & Regulatory
Aspinwall discloses two Tamil Nadu GST orders demanding Rs.0.27 Crore in tax, interest and penalty. The company plans to appeal, citing no material impact.
- Value
- ₹0.27 Cr
AstraZeneca Pharma India Legal & Regulatory
Delhi High Court directed NPPA to refrain from coercive steps on Rs.151.20 Crore alleged Symbicort Turbuhaler overcharging. Next hearing is January 11, 2027.
- Value
- ₹151.2 Cr
Jindal Poly Films Legal & Regulatory
Jindal Poly Films disclosed an NCLT petition under Sections 241-242 against Brookfield-linked investor Project Holdings Fourteen over oppression and mismanagement of subsidiary JPL Films. Related arbitration and Delhi High Court proceedings are pending, with financial impact not quantifiable.
Patel Chem Specialities Legal & Regulatory
BSE imposed a ₹0.01 Crore fine on Patel Chem Specialties for perceived LODR Reg 34 non-compliance. The company disputes the penalty, citing an inadvertent filing-year selection error.
- Value
- ₹0.01 Cr
Jyoti Legal & Regulatory
Jyoti Ltd received a rectification order from the Income Tax Department for AY 2020-21. The order levies an income tax demand of Rs.6.82 Crore including interest.
- Value
- ₹6.82 Cr